久久久久亚洲AV无码专区体验,脱了内裤猛烈进入A片视频免费,精品一区二区三区免费视频,BL肉YIN荡NP公厕肉便

熱門(mén)搜索: 硫酸角質(zhì)素(KS)ELISA試劑盒(種屬:魚(yú)) 白介素6(IL6)ELISA試劑盒(種屬:魚(yú)) 魚(yú)白介素10(IL10)ELISA試劑盒發(fā)貨及時(shí) 斑馬魚(yú)白介素12BELISA試劑盒發(fā)貨及時(shí) 兔載脂蛋白B(apo-B)ELISA試劑盒發(fā)貨及時(shí) 兔孕酮(PROG)ELISA試劑盒發(fā)貨及時(shí) 兔羥脯氨酸(Hyp)ELISA試劑盒發(fā)貨及時(shí) 兔抗酒石酸酸性磷酸酶ELISA試劑盒發(fā)貨及時(shí) 兔晶體蛋白α(Cryα)ELISA試劑盒發(fā)貨及時(shí) 兔結(jié)締組織生長(zhǎng)因子ELISA試劑盒發(fā)貨及時(shí) 兔基質(zhì)金屬蛋白酶9ELISA試劑盒發(fā)貨及時(shí) 兔肺表面活性物質(zhì)相ELISA試劑盒發(fā)貨及時(shí) CD206分子ELISA試劑盒(種屬:小鼠) CC趨化因子受體6ELISA試劑盒(種屬:小鼠) 阻抑素(PHB)ELISA試劑盒(種屬:大鼠) 中性?xún)?nèi)肽酶;腦啡ELISA試劑盒(種屬:大鼠)

技術(shù)文章/ Technical Articles

您的位置:首頁(yè)  /  技術(shù)文章  /  人不對(duì)稱(chēng)二甲基精氨酸(ADMA)ELISA試劑盒 “仁捷生物”產(chǎn)品文獻(xiàn)

人不對(duì)稱(chēng)二甲基精氨酸(ADMA)ELISA試劑盒 “仁捷生物”產(chǎn)品文獻(xiàn)

更新時(shí)間:2019-08-27      瀏覽次數(shù):1408

“仁捷生物”產(chǎn)品文獻(xiàn):Clinical Value of Asymmetrical Dimethylarginine Detection in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

-----------------------------------------------------------------------------------------------------------------------

 

Juan Liu , Qiang Fu, Lili Jiang, and Youlian Wang

Department of Rheumatology, Jiangxi Provincial People’s Hospital, Nanchang 330006, China

Correspondence should be addressed to Youlian Wang; 

Received 4 April 2019; Revised 29 May 2019; Accepted 27 July 2019; Published 14 August 2019

Guest Editor: Yan Yang

Copyright © 2019 Juan Liu et al.-is is an open access article distributed under the Creative Commons Attribution License, which

permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Objective. To evaluate the clinical value of serum asymmetrical dimethylarginine (ADMA) in patients with connective tissue

disease- (CTD-) associated pulmonary arterial hypertension (PAH). Methods. 88 patients with CTD were recruited between

December 2017 and August 2018 in Jiangxi Provincial People’s Hospital. Patients were further divided into two groups: CTD

without PAH (n = 45 cases) and CTD-with PAH (n = 43 cases), according to the pulmonary systolic blood pressure measured by

echocardiography. 40 healthy controls were also included (n =40 cases). -e clinical data, including laboratory examinations,

echocardiographic measurements, pulmonary function, and serum ADMA levels determined by enzyme-linked immunosorbent

assay, (ELISA) were collected. -e correlation between ADMA levels and the occurrence of PAH, pulmonary function, and other

laboratory indexes in CTD patients were analyzed. Statistical analyses were performed by SPSS (version 23); P < 0.05 was

considered statistically signifificant. Results. -e serum levels of ADMA in the CTD-PAH group were signifificantly higher than

those of the CTD-without PAH group and healthy control group (P < 0.05); the serum ADMA levels were (0.706 ± 0.153 μmol/L),

(1.015 ± 0.122 μmol/L), and (0.661 ± 0.113 μmol/L), respectively. -ere was no signifificant difffference between the CTD-without

PAH group and healthy control group (P < 0.05). Correlation analysis showed that serum ADMA levels were positively correlated

with sPAP and NT-proBNP and negatively correlated with DLCO% (r =0.802, 0.475, 0.585, P < 0.001). M*riate analysis

indicated that elevated serum ADMA levels increased the risk for the appearance of PAH in CTD patients (OR =57.460,

P < 0.001). Using the receiver operating characteristic (ROC) curve analysis, at the cutoffff level of 0.810 μmol/L, ADMA showed

good diagnostic effiffifficacy as follows: sensitivity was 97.7%, specifificity was 75.6%, and the area under the curve (AUC) was 0.947

(P < 0.001). Conclusion. Increased ADMA levels are independently associated with the presence and severity of PAH in CTD

patients. -e levels of ADMA in the serum may contribute to be a noninvasive indicator for early diagnosis of CTD-with PAH patients.

 

Blood samples for measurement of serum ADMA concentrations were naturally coagulated at room temperature for 20 minutes and centrifuged for about 20 minutes (3000 rpm), and the supernatants were stored in 1 mL aliquots at −80°C until further use. Concentration of ADMA was measured in serum samples by using an enzyme immunoassay ELISA kit provided by Shanghai Renjie Biotechnology Co., Ltd. The whole detection process was completed in strict accordance with the operating instructions. The absorbance (OD) was measured at 450 nm by using a Microplate reader, and each sample was duplicated.

 

ELISA試劑盒:人不對(duì)稱(chēng)二甲基精氨酸(ADMA)ELISA試劑盒 

 

產(chǎn)品貨號(hào):RJ11983

微信掃一掃

郵箱:2450868877@qq.com

傳真:86-區(qū)號(hào)-傳真號(hào)碼

地址:上海市楊浦區(qū)鐵嶺路32號(hào)1519-10室

Copyright © 2024 上海仁捷生物科技有限公司版權(quán)所有   備案號(hào):滬ICP備16052159號(hào)-1   總訪(fǎng)問(wèn)量:254849   技術(shù)支持:化工儀器網(wǎng)

TEL:17302193538

掃碼加微信